Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Diest, R.
Right arrow Articles by Appels, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Diest, R.
Right arrow Articles by Appels, A.
Related Collections
Right arrow Hematology
Right arrow Sleep and Biological Rhythms
Right arrow Coronary Artery Disease
Psychosomatic Medicine 64:787-792 (2002)
© 2002 American Psychosomatic Society


ORIGINAL ARTICLES

Diurnal Variations in Coagulation and Fibrinolysis in Vital Exhaustion

Rob van Diest, PhD, Karly Hamulyák, MD, Willem J. Kop, PhD, Carina van Zandvoort, MSc and Ad Appels, PhD

From the Departments of Psychiatry and Neuropsychology (R.v.D.), Hematology (K.H., C.v.Z.), Medical, Clinical, and Experimental Psychology (A.A.), Maastricht University, Maastricht, The Netherlands; and the Department of Medical and Clinical Psychology (W.J.K.), Uniformed Services University of the Health Sciences, Bethesda, MD.

Address reprints requests to: R. van Diest, Department of Psychiatry and Neuropsychology, Maastricht University, Box 616, 6200 MD Maastricht, The Netherlands. Email: rob.vandiest{at}pn.unimaas.nl

OBJECTIVE: Vital exhaustion (VE) predicts a first myocardial infarction (MI) and new cardiac events after a coronary angioplasty. To explore potential underlying pathophysiological mechanisms, we tested whether VE is associated with more pronounced diurnal variations in hemostasis.

METHODS: Blood was drawn from 29 VE and 30 control males, all healthy and nonsmokers, to assess hemostatic measures at 7:00 AM and 6:00 PM.

RESULTS: All measures of fibrinolysis were in their normal range and showed significant diurnal variations. These variations were more pronounced in VE as all fibrinolytic measures were significantly higher in VE at 7:00 AM and similar to those of controls at 6:00 PM, thus supporting our hypothesis with respect to fibrinolysis. Diurnal decreases in tPA and tPA-PAI ranged from 1.5 (VE) to 1.3 (controls), whereas the diurnal decrease in PAI-1 was more than fourfold in VE and 2.7-fold in controls. This suggests a decreased fibrinolytic capacity in VE during the early morning. All coagulation measures were in their normal range, and prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complexes, and activated factor VII showed significant diurnal variations. These variations were similar in VE and control individuals, thus not supporting our hypothesis with respect to coagulation. Finally, F1+2 and fibrinogen were both significantly higher throughout the day in VE.

CONCLUSIONS: VE is associated with decreased early morning fibrinolysis and increased fibrinogen levels throughout the day. These hemostatic changes may promote thrombus formation and provide a potential pathophysiological mechanism by which VE is related to MI and its circadian variation.

Key Words: stress, • coagulation, • fibrinolysis, • diurnal variations, • myocardial infarction.

Abbreviations: AF = alkaline phosphatase;; ALAT = alanin-aminotransferase;; ASAT = aspartic-aminotransferase;; BMI = body mass index;; CAD = coronary artery disease;; CV = intraassay coefficient of variation;; EDTA = ethylenediaminetetraacetic;; ELISA = enzyme-linked immunosorbent assay;; FNG = fibrinogen;; F1+2 = prothrombin fragment 1+2;; {gamma}-GT = gamma-glutamyl transferase;; GSQ = Groningen sleep questionnaire;; LDH = lactate dehydrogenase;; Ldlevel = lower detection level;; MI = myocardial infarction;; MIVE = Maastricht interview vital exhaustion;; MQ = Maastricht questionnaire;; PAI-1:act = plasminogen activator inhibitor activity;; PSS = perceived stress scale;; RR = relative risk;; SCID = structured clinical interview for DSM-IV;; SEM = standard error of the mean;; TAT = thrombin-antithrombin complexes;; tPA:ag = tissue plasminogen activator antigen;; tPA-PAI:ag = tPA-PAI complexes’ antigen;; VE = vital exhaustion;; VII:a = activated factor VII;; VII:c, VIII:c = factor VII and VIII coagulant activity;; vWf:ag = von Willebrand factor antigen.




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
B. T. Mausbach, R. von Kanel, K. Aschbacher, S. K. Roepke, J. E. Dimsdale, M. G. Ziegler, P. J. Mills, T. L. Patterson, S. Ancoli-Israel, and I. Grant
Spousal Caregivers of Patients With Alzheimer's Disease Show Longitudinal Increases in Plasma Level of Tissue-Type Plasminogen Activator Antigen
Psychosom Med, October 1, 2007; 69(8): 816 - 822.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. R. Rudnicka, A. Rumley, G. D.O. Lowe, and D. P. Strachan
Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population
Circulation, February 27, 2007; 115(8): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. van der Ven, R. van Diest, K. Hamulyak, M. Maes, C. Bruggeman, and A. Appels
Herpes Viruses, Cytokines, and Altered Hemostasis in Vital Exhaustion
Psychosom Med, March 1, 2003; 65(2): 194 - 200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Psychosomatic Society